Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name |
DrugCom ID |
Component Drug |
Indication |
REF |
Abexinostat + CA4P
|
DCA47F5
|
Abexinostat
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
ABT-263 + CA4P
|
DC5V4CT
|
ABT-263
|
Glioblastoma (Cell Line: JHH-136)
|
[3] |
Afatinib + CA4P
|
DCD6E4L
|
Afatinib
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
BMS-754807 + CA4P
|
DC3Z6AN
|
BMS-754807
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
CA4P + Gefitinib
|
DCGV69I
|
Gefitinib
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
CA4P + GDC0941
|
DCKIFTU
|
GDC0941
|
Glioblastoma (Cell Line: JHH-136)
|
[2] |
CA4P + Ruxolitinib
|
DC3Z552
|
Ruxolitinib
|
T-cell leukemia/lymphoma (Cell Line: ED-40515)
|
[2] |
CA4P + PD-0325901
|
DCTPSTS
|
PD-0325901
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
CA4P + Trametinib
|
DCC4G7O
|
Trametinib
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
CA4P + Trametinib
|
DCKM6F1
|
Trametinib
|
Glioblastoma (Cell Line: JHH-136)
|
[2] |
CA4P + Cladribine
|
DCPK56Z
|
Cladribine
|
Glioblastoma (Cell Line: JHH-136)
|
[2] |
CA4P + JQ1
|
DCO26JX
|
JQ1
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
CA4P + JQ1
|
DCU06XJ
|
JQ1
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
CA4P + Panobinostat
|
DCJR0ZO
|
Panobinostat
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
CA4P + Panobinostat
|
DCHEZJK
|
Panobinostat
|
Glioblastoma (Cell Line: JHH-136)
|
[2] |
CA4P + Ym155
|
DCAJJ87
|
Ym155
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
CA4P + RTB101
|
DCRLOPH
|
RTB101
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
CA4P + Fostamatinib
|
DCIANR9
|
Fostamatinib
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
CA4P + AZD8055
|
DCC17X1
|
AZD8055
|
Glioblastoma (Cell Line: JHH-136)
|
[2] |
CA4P + Cantharidin
|
DCV9U6W
|
Cantharidin
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
CA4P + Evacetrapib
|
DCR8V32
|
Evacetrapib
|
Glioblastoma (Cell Line: JHH-136)
|
[2] |
CA4P + SCH 727965
|
DC68EX1
|
SCH 727965
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
CA4P + Daporinad
|
DC0ML31
|
Daporinad
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
CA4P + THAPSIGARGIN
|
DCOGAGW
|
THAPSIGARGIN
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
CA4P + SNS-032
|
DCPGWTM
|
SNS-032
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
CA4P + GDC-0980/RG7422
|
DC35FTU
|
GDC-0980/RG7422
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
CA4P + GDC-0980/RG7422
|
DC3H74G
|
GDC-0980/RG7422
|
Glioblastoma (Cell Line: JHH-136)
|
[2] |
CA4P + Mitomycin
|
DCSUFVV
|
Mitomycin
|
Diffuse large B cell lymphoma (Cell Line: TMD8)
|
[2] |
CA4P + SNDX-275
|
DCNCZQN
|
SNDX-275
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
CA4P + OSI-027
|
DCLUSNN
|
OSI-027
|
Glioblastoma (Cell Line: JHH-136)
|
[2] |
CA4P + Flavopiridol
|
DCS4BQR
|
Flavopiridol
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
CA4P + AS602868
|
DCAH5I9
|
AS602868
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
CA4P + Tamoxifen
|
DC8JBGF
|
Tamoxifen
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
CA4P + Ciclopirox
|
DCRJAVG
|
Ciclopirox
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
CA4P + Mebendazole
|
DCHSO8B
|
Mebendazole
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
CA4P + Bardoxolone methyl
|
DC3XF8I
|
Bardoxolone methyl
|
Glioblastoma (Cell Line: JHH-136)
|
[2] |
CA4P + BIIB-021
|
DCJRX1D
|
BIIB-021
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
CA4P + Obatoclax
|
DCW09TM
|
Obatoclax
|
Glioblastoma (Cell Line: JHH-136)
|
[2] |
CA4P + BMS-754807
|
DC26UV6
|
BMS-754807
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
CA4P + PF-04691502
|
DCI5SJW
|
PF-04691502
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
CA4P + Dasatinib
|
DCIOTLP
|
Dasatinib
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[2] |
CA4P + Ruxolitinib
|
DC9LTBX
|
Ruxolitinib
|
Hodgkin lymphoma (Cell Line: L-1236)
|
[3] |
Marimastat + CA4P
|
DCZTE63
|
Marimastat
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
Mebendazole + CA4P
|
DCBQVJ6
|
Mebendazole
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
Mebendazole + CA4P
|
DCHTZ61
|
Mebendazole
|
Glioblastoma (Cell Line: JHH-136)
|
[2] |
MK-2206 + CA4P
|
DC1ZTB8
|
MK-2206
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
THZ1 + CA4P
|
DCNI4FE
|
THZ1
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
Trametinib + CA4P
|
DCW6XU0
|
Trametinib
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[3] |
------------------------------------------------------------------------------------ |
|
|
|
|